Contineum Therapeutics, Inc. ($CTNM)
Lorrain Daniel S. โ Chief Scientific Officer
Shares
100
Price
$1.01
Total Value
$101.00
Nearby Earnings
Mar 5, 2026
EPS:Est: -0.50
Revenue:Est: $5.00M
Transaction Details
| Insider | Lorrain Daniel S. |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 19, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Class A Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Shares Purchased | 100 |
| Price per Share | $1.01 |
| Total Value | $101.00 |
| Shares Owned After | 156,152 |
| Derivative | No |
| Accession Number | 0001437749-26-004912 |
| Document | View SEC Filing |